After experiencing dementia in his own family, the fitness guru is working on the ‘Think Brain Health’ campaign with ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

Euronews Health looks at some of this year’s top medical advances and the key areas of health that were the most solicited ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

Scientists believe the weight-loss jab's role in reducing inflammation in the body is key as this is common to other ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

GLP-1 inhibitor drugs might affect everything from food noise to Alzheimer's. Experts answer your top questions about their ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Novo Nordisk could also post results for semaglutide, the active ingredient in Wegovy and Ozempic, in treating patients with ...